Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Propylhexedrine |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergotoxine (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetryzoline (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naphazoline (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasoconstrictor drug poisoning |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental ergot alkaloid poisoning |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional ergot alkaloid poisoning |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot alkaloid poisoning of undetermined intent |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasoconstrictor adverse reaction |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ergot compound adverse reaction |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergocornine and dihydroergocristine and dihydroergocryptine adverse reaction |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot alkaloid adverse reaction |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesylate adverse reaction |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergometrine adverse reaction |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasoconstrictor allergy |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot compound allergy |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergocornine and dihydroergocristine and dihydroergocryptine allergy |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot alkaloid allergy |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydroergotamine mesylate allergy |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to ergometrine (finding) |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasoconstrictor drug overdose |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ergot alkaloid overdose (disorder) |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental ergot alkaloid overdose |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional ergot alkaloid overdose |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot alkaloid overdose of undetermined intent |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-dergocrine mesylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-dergocrine mesylate 1.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergoloid mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Menthol+benzoin inhalation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Menthol+eucalyptus inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Menthol 35.55mg inhalant capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine hydrochloride 10 mg/mL nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine hydrochloride [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dihydroergocornine and dihydroergocristine and dihydroergocryptine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Decongestant phenylephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxymetazoline (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine 0.125% solution nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine 0.25% solution nasal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine 0.5% solution nasal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine 1% solution nasal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine sulfate 2.5 mg/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by ergot alkaloid |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Felypressin (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as vasoconstrictor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as decongestant (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nasal decongestant preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-dergocrine |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tramazoline hydrochloride+dexamethasone isonicotinate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tramazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Frovatriptan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergot alkaloid |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasoconstrictor allergy |
Causative agent (attribute) |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naphazoline nitrate |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naphazoline hydrochloride (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxymetazoline hydrochloride |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetryzoline hydrochloride |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ornipressin (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Racephedrine |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Corbadrine |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Almotriptan malate |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Almotriptan |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaraminol (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Almotriptan hydrogen malate (substance) |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metaraminol bitartrate |
Is a |
False |
vasoconstricteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|